Galantamine improved cognition and global functioning in vascular dementia or Alzheimer disease with cerebrovascular disease

Larson, Eric
November 2002
ACP Journal Club;Nov/Dec2002, Vol. 137 Issue 3, p102
Academic Journal
Discusses research being done on the efficacy of galantamine in improving cognitive ability and global functioning in patients with probable vascular dementia or Alzheimer disease with cerebrovascular disease. Reference to study by T. Erkinjuntii and colleagues, published in the April 2002 issue of the journal 'Lancet'; Information on the study population; Intervention administered to the patients.


Related Articles

  • Link Between Alzheimer's and Vascular Dementia Holds Promise.  // Worldwide Biotech;Oct99, Vol. 11 Issue 10, p2 

    Reports that medications are being studied that are designed to treat Alzheimer's disease and vascular dementia and thus could help simplify the treatment of so-called `mixed dementia.' Cause of mixed dementia; Results of clinical trials of propentofylline that involved patients with vascular...

  • Estimation of the Absolute Bioavailability of Rivastigmine in Patients with Mild to Moderate Dementia of the Alzheimer’s Type. Hossain, M.; Jhee, S.S.; Shiovitz, T.; McDonald, C.; Sedek, G.; Pommier, F.; Cutler, N.R. // Clinical Pharmacokinetics;2002, Vol. 41 Issue 3, p225 

    Objective: To investigate the bioavailability of rivastigmine, an approved therapy for patients with mild to moderate dementia of the Alzheimer’s type, at the highest approved single dose of 6mg. Design and setting: Randomised, two-period crossover, single-centre, non-blinded, inpatient...

  • Cure for Alzheimer's by 2025? O'Connor, John // McKnight's Long-Term Care News;Apr2012, Vol. 33 Issue 4, p3 

    The article presents information on National Alzheimer's Plan which will cure dementia and Alzheimer's disease in the U.S. by 2025.

  • Symbolic Entropy of the Amplitude rather than the Instantaneous Frequency of EEG Varies in Dementia. Pei-Feng Lin; Jenho Tsao; Men-Tzung Lo; Chen Lin; Yi-Chung Chang // Entropy;2015, Vol. 17 Issue 2, p560 

    The dynamics of human electroencephalography (EEG) have been proved to be related to cognitive activities. This study separately assessed the two EEG components, amplitude and rhythm, aiming to capture their individual contributions to cognitive functions. We extracted the local peaks of EEGs...

  • Cerebrolysin. Plosker, Greg L.; Gauthier, Serge // Drugs & Aging;2009, Vol. 26 Issue 11, p893 

    Cerebrolysin is a parenterally administered, porcine brain-derived peptide preparation that has pharmacodynamic properties similar to those of endogenous neurotrophic factors. In several randomized, double-blind trials of up to 28 weeks' duration in patients with Alzheimer's disease,...

  • Dietary approach for cognitive and behavioral problems in dementia. Bhandari, Prasan R. // International Journal of Nutrition, Pharmacology, Neurological D;Oct2013, Vol. 3 Issue 4, p398 

    The article discusses a dietary approach for cognitive and behavioral problems in dementia. It describes the anti-amyloidogenic effect of a carotenoid from the stigma of the saffron flower called crocin. It also offers information on other common dietary ingredients that have a beneficial effect...

  • What's That Herb Again…? Ginkgo for Dementia. Greenfield, Russell H. // Alternative Medicine Alert;Jan2009, Vol. 12 Issue 1, p12 

    THE AUTHORS OF THIS MULTICENTER, RANDOMIZED, double-blind trial study (The Ginkgo Evaluation of Memory study) sought to determine whether use of a standardized extract of Ginkgo biloba over time would decrease the incidence of all-cause dementia, especially Alzheimer's disease, in people older...

  • Reversal of memory deficits by ethanolic extract of Mimusops elengi Linn. in mice. Joshi, Hanumanthachar; Parle, Milind // Pharmacognosy Journal;May/Jun2012, Vol. 4 Issue 29, p30 

    Background: Management of cognitive disorders like dementia and Alzheimer's disease has been challenging since no potential drug is available with proved efficacy. Some nootropic drugs like piracetam, aniracetam and cholinesterase inhibitors such as Donepezil® have found to exhibit severe...

  • BACE1 Deficient Mice: Their Role in Drug Target Validation and Implications for Alzheimer's Disease Therapies. Vassar, Robert // Current Medicinal Chemistry - Immunology, Endocrine & Metabolic ;Mar2003, Vol. 3 Issue 1, p47 

    A large (and still growing) body of evidence suggests that the �-amyloid peptide (A�) is central to the pathophysiology of Alzheimer's Disease (AD) and may in fact initiate disease processes that lead to this intractable neurodegenerative disorder. Amyloid plaques composed of A�...


Read the Article


Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics